Breaking News Instant updates and real-time market news.

ORCL

Oracle

$46.30

-1.975 (-4.09%)

, AMZN

Amazon.com

$1,715.29

10.49 (0.62%)

10:18
06/14/18
06/14
10:18
06/14/18
10:18

Oracle slides as JPMorgan cuts rating on business lost to Amazon, Microsoft

Shares of Oracle (ORCL) are sliding after JPMorgan analyst Mark Murphy downgraded the stock to Neutral, citing negative results from a survey of Chief Information Officers about their spending. The analyst noted that the survey showed spending contraction ahead as Oracle's databases are being unplugged in favor of Microsoft (MSFT) and Amazon (AMZN) databases. SURVEY SAYS: In a research note this morning, JPMorgan's Murphy downgraded Oracle to Neutral from Overweight as specific metrics in the firm's large-scale CIO survey have arced over into negative territory. The analyst told investors that while Oracle's shares have risen from the $30s into the high $40s in the last 2 years, the company's fundamental performance has remained inconsistent. Citing his survey of 154 CIOs, Murphy noted that Oracle received the largest number of indications for planned spending contraction this year, materially more than the second-worst company, which was IBM (IBM) with 25 indications of spending contraction. Further, while ranking the top 8 or 9 mega-vendors in terms of who will be most critical and indispensable to CIOs' IT environment in the future, Oracle only received 6.5% of votes, down from 11% in previous surveys, the analyst highlighted. At the same time, Murphy pointed out that Amazon AWS improved from 9.5% of votes last year to 14.9% of votes this year, creating the appearance of a "sucking sound" out of Oracle and into AWS. The company also ranked number 8 in terms of association with Digital Transformation projects, disappointing relative to its scale and lagging behind the likes of SAP (SAP), IBM, and Cisco (CSCO), he added, noting that despite Oracle's efforts to build a Cloud presence, it rated no better than SAP in terms of association with Cloud Computing plans, and is nowhere close to the leaders Microsoft, Amazon, and Google (GOOGL; GOOG) in this respect. Oracle was mentioned by only 2% of the CIOs as the platform that will be "most integral" to their cloud computing plans, Murphy said. Overall, the analyst questions where Oracle's business and stock are heading in the next couple of years if the largest-scale CIO survey shows Oracle now has negative spending intentions, is lagging in Digital Transformation projects, is trailing in Cloud Computing plans, its databases are being unplugged in favor of Microsoft and Amazon databases, its applications are being unplugged in favor of Salesforce (CRM) and Workday (WDAY) applications, and customers are weary of its unpopular commercial tactics. Murphy also lowered his price target on Oracle's shares to $53 from $55. WHAT'S NOTABLE: In a research note of his own, Nomura Instinet analyst Christopher Eberle lowered his price target for Oracle to $60 from $64 ahead of the company's fourth quarter results on June 19. The analyst trimmed his estimates to account for currency and expectations for more modest revenue acceleration in fiscal 2019. He remains optimistic, however, on Oracle's transition and model growth reacceleration as the year progresses. Eberle reiterated a Buy rating on the shares. PRICE ACTION: In morning trading, shares of Oracle dropped almost 5% to $46.14.

ORCL

Oracle

$46.30

-1.975 (-4.09%)

AMZN

Amazon.com

$1,715.29

10.49 (0.62%)

MSFT

Microsoft

$101.39

0.49 (0.49%)

IBM

IBM

$146.76

0.43 (0.29%)

SAP

SAP

$120.74

0.25 (0.21%)

CSCO

Cisco

$44.54

0.52 (1.18%)

GOOG

Alphabet

$1,146.30

11.91 (1.05%)

GOOGL

Alphabet Class A

$1,156.58

12.46 (1.09%)

CRM

Salesforce

$138.92

2.46 (1.80%)

WDAY

Workday

$129.41

2.97 (2.35%)

  • 14

    Jun

  • 14

    Jun

  • 14

    Jun

  • 14

    Jun

  • 14

    Jun

  • 14

    Jun

  • 15

    Jun

  • 19

    Jun

  • 20

    Jun

  • 22

    Jun

  • 10

    Jul

  • 10

    Jul

  • 12

    Jul

  • 28

    Oct

ORCL Oracle
$46.30

-1.975 (-4.09%)

06/14/18
JPMS
06/14/18
DOWNGRADE
Target $53
JPMS
Neutral
Oracle downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Mark Murphy downgraded Oracle to Neutral and lowered his price target for the shares to $53 from $55.
06/14/18
JPMS
06/14/18
DOWNGRADE
Target $53
JPMS
Neutral
JPMorgan downgrades Oracle after CIO survey shows spending contraction
JPMorgan analyst Mark Murphy downgraded Oracle (ORCL) to Neutral from Overweight and lowered his price target for the shares to $53 from $55. The stock closed yesterday down 18c to $48.27. The shares have risen from the $30s into the high $40s over the last two years, but the company's fundamental performance has remained inconsistent, Murphy tells investors in a research note. Further, the analyst notes that in his firm's recent survey of 154 chief investment officers, Oracle received the largest number of indications for planned spending contraction this year, materially more than the second-worst company. The CIOs indicate contraction in Oracle spending this year, placing the company alongside IBM (IBM), Checkpoint (CHKP), and CA (CA), Murphy contends. He notes the results of his firm's CIO surveys over the years "have been highly predictive."
06/14/18
06/14/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Oracle (ORCL) downgraded to Neutral from Overweight at JPMorgan with analyst Mark Murphy saying the shares have risen from the $30s into the high $40s over the last two years, but the company's fundamental performance has remained inconsistent. 2. Kohl's (KSS) downgraded to Neutral from Buy at Citi with analyst Paul Lejuez citing valuation. 3. Toll Brothers (TOL) downgraded to Hold from Buy at Zelman. 4. PGT, Inc. (PGTI) downgraded to Hold on valuation at Gabelli with analyst Alvaro Lacayo citing valuation. 5. XPO Logistics (XPO) downgraded to Neutral from Buy at BofA/Merrill with analyst Ariel Rosa citing limited upside following the recent gain in shares. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/14/18
NOMU
06/14/18
NO CHANGE
Target $60
NOMU
Buy
Oracle price target lowered to $60 from $64 at Nomura Instinet
Nomura Instinet analyst Christopher Eberle lowered his price target for Oracle to $60 ahead of the company's Q4 results on June 19. The analyst trimmed his estimates to account for currency and expectations for more modest revenue acceleration in fiscal 2019. He remains optimistic, however, on Oracle's transition and model growth reacceleration as the year progresses. Eberle keeps a Buy rating on the shares, which JPMorgan this morning downgraded to Neutral.
AMZN Amazon.com
$1,715.29

10.49 (0.62%)

06/11/18
BARD
06/11/18
NO CHANGE
Target $90
BARD
Outperform
Target price target raised to $90 from $85 at Baird
Baird analyst Peter Benedict raised his price target on Target (TGT) to $90 and kept his Outperfom rating, saying 2018 marks the year of "aggressive scaling" of same-day and next-day fulfillment option that rivals "any retailer in the market", including Amazon (AMZN) and Walmart (WMT). The analyst further contends that given the improving profitability trends, "Target remains a stock to own".
06/08/18
BERN
06/08/18
NO CHANGE
BERN
Bernstein offers list of possible CEOs for Amazon-Berkshire-JPMorgan venture
After Berkshire' (BRK.A) Warren Buffett and JPMorgan's (JPM) Jamie Dimon announced on CNBC that they have selected a CEO for their healthcare joint venture with Amazon (AMZN) and added that they would announce the name in about two weeks, Bernstein analyst Lance Wilkes noted that Geisinger CEO David Feinberg denied accepting the position and said he is committed to Geisinger. The ultimate choice of the CEO will inform on the intended scope of the NewCo and how the companies will prioritize strategic direction and needed capabilities, said Wilkes, who offered a list of potential CEO candidates that includes Gary Loveman, Rick Jelinek, Matt Manders, Patrick Conway, Amir Rubin, Owen Tripp, Chris Grant, Marc Harrison, Andy Slavitt, Todd Park and Peter Orszag.
06/14/18
DADA
06/14/18
NO CHANGE
Target $2100
DADA
Buy
Amazon.com price target raised to $2,100 from $1,900 at DA Davidson
DA Davidson analyst Tom Forte raised his price on Amazon.com to $2,100 and kept his Buy rating, citing his updated model projecting incremental revenue generated by the company's private-label and ad efforts relative to his prior forecasts. Forte says he is raising his sales growth projections by 1% for the forward years and still expects longer-term adjusted EBITDA margin to reach 20% vs. 11.1% in 2017.
06/13/18
MSCO
06/13/18
NO CHANGE
MSCO
Morgan Stanley says AT&T ruling may help narrow public/private media value gap
Morgan Stanley analyst Benjamin Swinburne said the court approval of AT&T's (T) acquisition of Time Warner (TWX) without conditions recognized the reality of new competition in the form of content investments from players such as Netflix (NFLX), Google's (GOOGL) YouTube, Amazon (AMZN), Apple (AAPL) and Facebook (FB). This ruling sends a "clear message to other industry players" and market uncertainty on deal prospects could fall, which could mean that equity values will likely rise accordingly, Swinburne tells investors. He notes there remains a large gap, which may now narrow, between private market valuations and public multiples in many parts of media and cable, pointing to Discovery Inc. (DISCK) as an example illustrating that point.
MSFT Microsoft
$101.39

0.49 (0.49%)

06/11/18
BERN
06/11/18
NO CHANGE
Target $123
BERN
Outperform
Microsoft kicks game up a notch, says Bernstein
Bernstein analyst Mark Moerdler notes that Microsoft is, "not surprisingly," increasing its investments in gaming by adding 5 new creative teams to Microsoft Studios, launching a brand-new gaming Studio - The Initiative, acquiring Playground Games, and announcing letters of intent to acquire Ninja Theory, Undead Labs and Compulsion Games. Microsoft is making numerous small acquisitions and launching significant new game development capability, he points out, adding that it is unlikely that Microsoft will make any large content creation acquisition after these announcements. The analyst reiterates an Outperform rating and $123 price target on the shares.
06/06/18
ARGS
06/06/18
NO CHANGE
Target $116
ARGS
Buy
Microsoft price target raised to $116 from $107 at Argus
Argus analyst Joseph Bonner maintained a Buy rating on Focus List choice Microsoft and raised his price target by $9 to $116 following the company's plans to acquire GitHub for $7.5B in stock, the second-largest acquisition in Microsoft's history. In a research note to investors, Bonner says the purchase is the biggest sign yet of the monumental shift in Microsoft's strategy and orientation under Satya Nadella, its CEO, and that Nadella has sought to shift the company to an open-source ethos that dovetails with its Azure cloud services business rather than seeking to protect Windows software at any cost. Bonner maintained his FY18 EPS forecast of $3.84 and FY19 forecast of $3.92.
06/12/18
MSCO
06/12/18
NO CHANGE
Target $130
MSCO
Overweight
Microsoft gaming model moving 'from Gillette to Netflix,' says Morgan Stanley
Morgan Stanley analyst Keith Weiss said announcements from E3 and his meeting with Executive VP of Gaming at Microsoft (MSFT), Phil Spencer, supported his view that the company's gaming division is "moving from Gillette to Netflix," meaning that its model is being transformed from a "razor/razor blade model" built on the Xbox console base towards a subscription gaming service streaming from Azure to all types of devices. Adding five new development studios to buttress Microsoft's first-party content particularly supported this view, said Weiss, who keeps an Overweight rating and $130 price target on Microsoft shares.
06/13/18
UBSW
06/13/18
NO CHANGE
Target $114
UBSW
Buy
Microsoft trading at discount to peers, says UBS
UBS analyst Jennifer Swanson Lowe believes Microsoft's current price undervalues both the emerging Cloud story and the durable on-premise legacy businesses. The analyst said Microsoft content is taking center stage as it acquired four game studios and formed a fifth. She also believes the strength of the Azure platform can be a differentiator for the company. Lowe reiterated her Buy rating and $114 price target on Microsoft shares.
IBM IBM
$146.76

0.43 (0.29%)

04/26/18
DADA
04/26/18
INITIATION
Target $72
DADA
Buy
Pegasystems initiated with a Buy at DA Davidson
DA Davidson analyst Rishi Jaluria initiated Pegasystems (PEGA) with a Buy rating and a price target of $72, citing the company's market leading position in the business process management and case management markets amid the crowing presence of customer relationship management technologies. Jaluria says the company continues to take market share from legacy vendors like IBM (IBM) and Oracle (ORCL) and increasing its competitive position in CRM, while driving opportunities for margin expansion.
06/14/18
RBCM
06/14/18
NO CHANGE
Target $180
RBCM
Outperform
IBM positioned for gross margin stabilization, says RBC Capital
RBC Capital analyst Amit Daryanani kept his Outperform rating and $180 price target on IBM, saying that it has underperformed in 2018 on investor concerns around its gross margin trajectory and sustainability of revenue growth. The analyst contends however that IBM is positioned for more stable gross margins for the rest of the year and a potential stabilization, "if not growth", in revenues, citing an expected recovery in its Global Business Services segment and a sustained growth in Cognitive and Technology Services & Cloud Platforms. Daryanani believes that the risk-reward on IBM is "attractive".
05/31/18
MSCO
05/31/18
NO CHANGE
Target $198
MSCO
Overweight
Morgan Stanley says report on 'mass layoffs' in IBM's Watson Health 'misleading'
Morgan Stanley analyst Katy Huberty said a report from The Register blog that implies "mass layoffs" in IBM's Watson Health unit are "misleading," stating that any such layoffs come after IBM reported $613M in restructuring with its April 17 earnings call and detailed about $100M of that was related to the Cognitive business division. The timing of the March restructuring charge aligns with fully integrating businesses such as Truven Health Analytics and Merge Healthcare into Watson Health, she added. As recently as its March investor day, IBM discussed aggressive hiring in strategic areas like oncology within Watson Health, suggesting any layoffs are gross reductions though its net headcount in Watson Health is likely still expanding, added Huberty, who has an Overweight rating and $198 price target on IBM shares.
SAP SAP
$120.74

0.25 (0.21%)

06/01/18
JEFF
06/01/18
INITIATION
Target $140
JEFF
Buy
SAP initiated with a Buy at Jefferies
Jefferies analyst Vijay Anand started SAP with a Buy rating and $140 price target. The analyst views the slower than expected progress in SAP's cloud gross margin improvement as "largely a timing issue." With the investment phase mostly over, the analyst expects SAP's free cash flow growth to accelerate and shares to re-rate as investors "fully appreciate the quality" of its cloud assets.
05/18/18
DADA
05/18/18
NO CHANGE
Target $31
DADA
Neutral
ProsHoldings price target raised to $31 from $28 at DA Davidson
DA Davidson analyst Rishi Jaluria raised his price target on ProsHoldings (PRO) to $31 following its user conference and investor session. The analyst cites the company's disclosed partnership with SAP Hybris (SAP) on joint projects in airline solutions and its "solid" expansion outside of travel. While Jaluria anticipates incremental benefits from the partnership, he keeps his Neutral rating due to valuation and worries about ProsHoldings' cash burn.
04/24/18
DBAB
04/24/18
NO CHANGE
DBAB
SAP removed from the short-term buy list at Deutsche Bank
03/12/18
03/12/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Time Warner (TWX) upgraded to Buy from Neutral at UBS with analyst John Hodulik saying while he expects the takeover by AT&T (T) to receive regulatory approval, he believes the current environment would make Time Warner's assets "highly attractive" to other media companies and Internet-based competitors were the deal to be blocked. 2. Carlyle Group (CG) and Apollo Global (APO) were upgraded to Buy from Neutral at Citi. 3. Merck (MRK) upgraded to Outperform from Market Perform at Leerink with analyst Seamus Fernandez saying Keytruda will continue to dominate the first-line non-small cell lung cancer market. 4. SAP (SAP) upgraded to Outperform from In Line at Evercore ISI with analyst Stewart Materne III saying that he believes the risk/reward is more attractive at current levels following the stock's 6% pullback. 5. Aratana Therapeutics (PETX) upgraded to Buy on valuation at CL King with the firm citing favorable risk/reward. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
CSCO Cisco
$44.54

0.52 (1.18%)

05/18/18
ARGS
05/18/18
NO CHANGE
Target $55
ARGS
Buy
Cisco price target raised to $55 from $50 at Argus
Argus analyst Jim Kelleher raised his price target on Cisco to $55 and kept his Buy rating after its Q3 results, saying the pullback in the stock price despite the above or in-line earnings and guidance suggests that investors were looking to take profits following a 30% run-up over the past year. Kelleher notes "good momentum" in the company's largest category - Enterprise - where orders were up in low double digits. The analyst also sees "multiple positives" in Cisco's outlook, such as rapid growth in CAT 9000, greater contribution from recurring revenue, and capital return potential from "exceptional" cash flows.
05/17/18
MSCO
05/17/18
NO CHANGE
Target $50
MSCO
Overweight
Cisco laying groundwork for upside in FY19, says Morgan Stanley
Following Cisco's report of "strong" Q3 results and "generally positive" comments from management regarding the outlook, Morgan Stanley analyst James Faucette said the earnings call "offered ample evidence" Cisco's software strategy is progressing well. He sees software helping to stabilize equipment replacement cycles and believes the stock will approach $50 as the market becomes more convinced FY19 estimates are too low. Faucette maintains an Overweight rating and $50 price target on Cisco shares.
06/04/18
COWN
06/04/18
NO CHANGE
Target $51
COWN
Outperform
Cisco cloud opportunity outweighs risk, says Cowen
Cowen analyst Paul Silverstein said Cisco management made a case that the emergence of Public Clouds, specifically the migration toward a Multi-Cloud IT world, presents the company with greater opportunity than risk. He said the case calls for revenue opportunities from both Public Cloud Operators and Enterprises as growth drivers. Silverstein reiterated his Outperform rating and $51 price target on Cisco shares.
05/17/18
RBCM
05/17/18
NO CHANGE
Target $50
RBCM
Outperform
Cisco post-earnings stock dip is a buying opportunity, says RBC Capital
RBC Capital analyst Mitch Steves kept his Outperform rating and $50 price target on Cisco, saying the slight pullback in the stock price following the in-line earnings and guidance may be a buying opportunity. The analyst cites continued growth in deferred revenues while also forecasting growth in Switching sales for 2-3 quarters given the backlog and its high margin levels. Steves also notes Cisco's history of buybacks when its stock price traded in $42-$44 per share range, creating a "nice support for the stock".
GOOG Alphabet
$1,146.30

11.91 (1.05%)

06/13/18
RSBL
06/13/18
NO CHANGE
RSBL
Sell
Applied Optoelectronics could be pressured by Google tightening, says Rosenblatt
Rosenblatt analyst Jun Zhang said checks point to a modest new tightening of capital spending at Alphabet's (GOOG) Google in Q2, which could lead to pressure on Applied Optoelectronics (AAOI). Among suppliers with modest exposure to Alphabet, Zhang currently sees minimal impact to Arista (ANET) and Juniper (JNPR). Zhang keeps a Sell rating on Applied shares.
06/05/18
ARGS
06/05/18
NO CHANGE
Target $229
ARGS
Buy
Palo Alto Networks price target raised to $229 from $201 at Argus
Argus analyst Joseph Bonner raised his price target for Palo Alto Networks (PANW) to $229 and maintained a Buy rating after the company exceeded its own forecasts and consensus estimates in Q3 and named former Google (GOOGL) Chief Business Officer Nikesh Arora as chairman and CEO. In a research note to investors, Bonner says Palo Alto appears to have moved past recent sales execution issues and that management has recognized and taken advantage of emerging industry trends.
06/04/18
RHCO
06/04/18
NO CHANGE
Target $2000
RHCO
Buy
'The best has yet to come' for Amazon, says SunTrust, raising PT to $2,000
SunTrust analyst Youssef Squali raised his price target on Amazon.com (AMZN) to $2,000 from $1,900 and maintained a Buy rating on shares, telling investors in a research note that "the best has yet to come" for Amazon. Squali sees more upside in the stock, and says Amazon is "one of our favorite names within our IDM group" with the company expanding into offline distribution, building a private label business at scale and challenging Facebook (FB) and Google (GOOGL) as a major marketing platform. He also contends that private label is one of the highly under appreciated trends within Amazon, which should, over time, give Amazon a strong "unfair" competitive advantage.
GOOGL Alphabet Class A
$1,156.58

12.46 (1.09%)

06/08/18
OTRG
06/08/18
NO CHANGE
OTRG
Alphabet search remained strong in Q2, says OTR Global
OTR Global's checks indicate Q2 spending growth on Google search remained strong, driven by robust pricing trends and AI adoption. Spending growth through mid-Q2 was in line to slightly ahead of Q1 momentum, helped by higher CPCs, PLA demand, and similar audiences.
CRM Salesforce
$138.92

2.46 (1.80%)

05/31/18
ROTH
05/31/18
NO CHANGE
Target $131
ROTH
Neutral
Salesforce price target raised to $131 from $112 at Roth Capital
Roth Capital analyst Richard Baldry raised his price target for Salesforce to $131 from $112, citing "good" results but noting that its strong reported earnings beat was largely driven by a gain realized on a strategic investment of roughly 22c to temper or enthusiasm. The analyst reiterates a Neutral rating on the shares.
05/30/18
RHCO
05/30/18
NO CHANGE
Target $146
RHCO
Buy
Salesforce price target raised to $146 from $133 at SunTrust
SunTrust analyst Terry Tillman raised his price target on Salesforce to $146 after its Q1 results, saying "fundamentals remained strong" in the quarter despite the noise in the financials from the ASC 606 adoption. Tillman notes that all product segments showed accelerating trends, and international operations were also "especially strong". The analyst views the stock as a "core large cap tech holding", keeping his Buy rating on Salesforce.
05/30/18
BERN
05/30/18
NO CHANGE
Target $135
BERN
Market Perform
Salesforce price target raised to $135 from $125 at Bernstein
Bernstein analyst Mark Moerdler raised his price target for Salesforce to $135 from $125 after another "good" quarter for the company. Nonetheless, the analyst continues to have long-term concerns regarding Salesforce's ability to expand its margin significantly as it decelerates, and reiterates a Market Perform rating on the shares.
05/30/18
BMOC
05/30/18
NO CHANGE
Target $147
BMOC
Outperform
Salesforce price target raised to $147 from $133 at BMO Capital
BMO Capital analyst Keith Bachman raised his price target on Salesforce (CRM) to $147 after its "solid" Q1 results across all metrics as well as "upside tension" in its guidance relative to estimates. The analyst says that while he was not supportive of the MuleSoft (MULE) deal, it will help Salesforce sustain its top-line growth over 2019, which should also boost the multiple. Excluding MuleSoft revenues and FX impact, Bachman sees Salesforce organic revenue growth of just over 20%. Longer term, the analyst keeps his Outperform rating on Salesforce, stating that its scale offers brand, sales, and cost advantages relative to other SaaS vendors, while the company also benefits from its integrated cloud platform set.
WDAY Workday
$129.41

2.97 (2.35%)

06/01/18
JEFF
06/01/18
NO CHANGE
Target $119
JEFF
Buy
Workday billings below expectations in Q1, says Jefferies
While Workday's Q1 results beat Street expectations on most metrics, billings came in below expectations, Jefferies analyst John DiFucci tells investors in a research note. The company reported no new large Financials wins, suggesting future adoption of the product will be gradual, the analyst adds. He views the Workday's fiscal year as more back-end loaded and keeps a Hold rating on the shares with a $119 price target.
06/01/18
WBLR
06/01/18
NO CHANGE
WBLR
Outperform
William Blair an 'aggressive' buyer of Workday on weakness
William Blair analyst Justin Furby recommends using the post-earnings pullback in shares of Workday as a buying opportunity. Workday's Q1 results had some "billings noise, but cutting through it, there were a number of bright spots," Furby tells investors in a research note. He would be "aggressive long-term buyers" on any stock weakness today. The analyst notes the company's new ACV bookings were above management's internal plan and increased year-over-year against the toughest comparison of the year.
06/11/18
MUFG
06/11/18
NO CHANGE
Target $145
MUFG
Overweight
MUFG recommends taking longer-term view of Workday acquisition of Adaptive
MUFG analyst Stephen Bersey notes that Workday announced plans to acquire all outstanding shares of Adaptive Insights for $1.55B, including $150M in unvested equity issued to Adaptive employees. This is the first major acquisition by Workday and the analyst believes that the acquisition should bolster its nascent Planning offering which is part of its Financial products suite. Bersey recommends looking at the acquisition over the longer-term, and reiterates an Overweight rating and $145 price target on Workday's shares.
06/11/18
JEFF
06/11/18
NO CHANGE
Target $119
JEFF
Hold
Workday strategic rationale for deal clear, integration less so, says Jefferies
After Workday announced an agreement to acquire Adaptive Insights, a Software-as-a-Service company that helps organizations handle corporate planning, Jefferies analyst John DiFucci said he sees a strategic rationale supporting the acquisition, but it is less clear how the integration of its platform with Workday's object-oriented infrastructure will be accomplished. If Adaptive Insights can be integrated with Cape Clear, which Workday previously bought in 2008, it raises the possibility of more future acquisitions, added DiFucci who keeps a Hold rating and $119 price target on Workday shares.

TODAY'S FREE FLY STORIES

CEQP

Crestwood Equity

$37.55

0.05 (0.13%)

19:40
09/23/18
09/23
19:40
09/23/18
19:40
Downgrade
Crestwood Equity rating change at Stifel »

Crestwood Equity…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PAGP

Plains GP Holdings

$24.16

-0.14 (-0.58%)

, PAA

Plains All American

$24.84

-0.08 (-0.32%)

19:37
09/23/18
09/23
19:37
09/23/18
19:37
Upgrade
Plains GP Holdings, Plains All American rating change at Stifel »

Plains GP Holdings…

PAGP

Plains GP Holdings

$24.16

-0.14 (-0.58%)

PAA

Plains All American

$24.84

-0.08 (-0.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PAA

Plains All American

$24.84

-0.08 (-0.32%)

19:36
09/23/18
09/23
19:36
09/23/18
19:36
Upgrade
Plains All American rating change at Stifel »

Plains All American…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMCSA

Comcast

$37.91

0.1 (0.26%)

, CMCSK

Comcast

$0.00

(0.00%)

19:30
09/23/18
09/23
19:30
09/23/18
19:30
Hot Stocks
Fly Intel: Top five weekend stock stories »

Catch up on the…

CMCSA

Comcast

$37.91

0.1 (0.26%)

CMCSK

Comcast

$0.00

(0.00%)

SKYAY

Sky

$0.00

(0.00%)

FOX

21st Century Fox

$43.97

-0.23 (-0.52%)

FOXA

21st Century Fox

$44.33

-0.26 (-0.58%)

RBC

Regal Beloit

$85.80

-0.25 (-0.29%)

TLRY

Tilray

$123.16

-53.365 (-30.23%)

BSX

Boston Scientific

$37.76

-0.07 (-0.19%)

ISRG

Intuitive Surgical

$556.70

-4.43 (-0.79%)

CAT

Caterpillar

$156.39

0.38 (0.24%)

AMAT

Applied Materials

$39.62

0.22 (0.56%)

BWA

BorgWarner

$45.24

-0.53 (-1.16%)

KEY

KeyCorp

$20.78

0.02 (0.10%)

PH

Parker-Hannifin

$190.52

0.01 (0.01%)

AAPL

Apple

$217.65

-2.35 (-1.07%)

CSCO

Cisco

$48.51

0.77 (1.61%)

INTC

Intel

$46.64

-0.56 (-1.19%)

IBM

IBM

$151.29

0.12 (0.08%)

MSFT

Microsoft

$114.70

1.13 (0.99%)

ORCL

Oracle

$51.08

0.65 (1.29%)

BRK.A

Berkshire Hathaway

$331,710.00

-1090 (-0.33%)

BRK.B

Berkshire Hathaway

$220.57

-1.24 (-0.56%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 25

    Sep

  • 25

    Sep

  • 26

    Sep

  • 26

    Sep

  • 26

    Sep

  • 27

    Sep

  • 29

    Sep

  • 03

    Oct

  • 04

    Oct

  • 05

    Oct

  • 09

    Oct

  • 10

    Oct

  • 18

    Oct

  • 21

    Oct

  • 22

    Oct

  • 22

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 28

    Oct

  • 30

    Oct

  • 28

    Nov

  • 03

    Mar

RBC

Regal Beloit

$85.80

-0.25 (-0.29%)

19:08
09/23/18
09/23
19:08
09/23/18
19:08
Earnings
Regal Beloit confirms 2018 adjusted diluted EPS guidance of $5.70-$6.00 »

Regal sees 2018 GAAP…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

RBC

Regal Beloit

$85.80

-0.25 (-0.29%)

19:04
09/23/18
09/23
19:04
09/23/18
19:04
Hot Stocks
Regal Beloit announces planned CEO retirement »

Regal Beloit announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

TRXC

TransEnterix

$6.43

-0.035 (-0.54%)

18:14
09/23/18
09/23
18:14
09/23/18
18:14
Hot Stocks
TransEnterix acquires assets, intellectual property from MST Medical Surgery »

TransEnterix announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 02

    Oct

  • 27

    Nov

T

AT&T

$33.88

0.44 (1.32%)

, CMCSA

Comcast

$37.91

0.1 (0.26%)

17:24
09/23/18
09/23
17:24
09/23/18
17:24
Hot Stocks
Box Office Battle: 'The House With a Clock in Its Walls' opens to $26.9M in U.S. »

Comcast (CMCSA)…

T

AT&T

$33.88

0.44 (1.32%)

CMCSA

Comcast

$37.91

0.1 (0.26%)

CMCSK

Comcast

$0.00

(0.00%)

SNE

Sony

$57.04

-2.065 (-3.49%)

FOX

21st Century Fox

$43.97

-0.23 (-0.52%)

FOXA

21st Century Fox

$44.33

-0.26 (-0.58%)

LGF.A

Lionsgate

$22.38

-0.09 (-0.40%)

DIS

Disney

$110.72

-0.9 (-0.81%)

VIAB

Viacom

$32.36

0.52 (1.63%)

VIA

Viacom

$34.50

-0.5 (-1.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 26

    Sep

  • 21

    Oct

  • 06

    Nov

  • 12

    Nov

DVMT

Dell Technologies

$96.27

0.27 (0.28%)

17:04
09/23/18
09/23
17:04
09/23/18
17:04
Periodicals
Dell to interview banks for IPO instead of acquisition, WSJ reports »

Dell Technologies is said…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WPP

WPP

$75.11

-0.06 (-0.08%)

16:23
09/23/18
09/23
16:23
09/23/18
16:23
Periodicals
WPP preparing to merge Young & Rubicam, digital ad firm VML, WSJ reports »

WPP new CEO Mark Read is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABT

Abbott

$69.05

0.25 (0.36%)

16:15
09/23/18
09/23
16:15
09/23/18
16:15
Hot Stocks
Abbott announces positive clinical study results from MitraClip trial »

Abbott announced positive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

AZN

AstraZeneca

$37.69

-0.025 (-0.07%)

12:59
09/23/18
09/23
12:59
09/23/18
12:59
Periodicals
AstraZeneca CEO warns of medicine shortages following Brexit, Reuters reports »

Britain could see…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VLKAY

Volkswagen

$0.00

(0.00%)

12:54
09/23/18
09/23
12:54
09/23/18
12:54
Periodicals
Volkswagen's Porsche dropping diesel in EV push, Reuters says »

Volkswagen's Porsche…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$217.65

-2.35 (-1.07%)

12:49
09/23/18
09/23
12:49
09/23/18
12:49
Periodicals
Apple planning for delays to Battersea HQ, Bloomberg reports »

Apple is making…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

PYPL

PayPal

$90.76

0.17 (0.19%)

12:43
09/23/18
09/23
12:43
09/23/18
12:43
Periodicals
PayPal replaces executive in charge of Venmo, WSJ reports »

PayPal is replacing the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

MDT

Medtronic

$97.85

0.38 (0.39%)

12:37
09/23/18
09/23
12:37
09/23/18
12:37
Hot Stocks
Medtronic presents IN.PACT global study three-year data »

Medtronic announced data…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Oct

CMCSA

Comcast

$37.91

0.1 (0.26%)

, CMCSK

Comcast

$0.00

(0.00%)

12:29
09/23/18
09/23
12:29
09/23/18
12:29
Hot Stocks
Comcast prevails with highest offer price in auction for Sky »

Comcast (CMCSA) published…

CMCSA

Comcast

$37.91

0.1 (0.26%)

CMCSK

Comcast

$0.00

(0.00%)

SKYAY

Sky

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDT

Medtronic

$97.85

0.38 (0.39%)

12:26
09/23/18
09/23
12:26
09/23/18
12:26
Hot Stocks
Clinical study shows safety, efficacy outcomes for Medtronic Resolute Onyx DES »

Investigators unveiled…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Oct

BSX

Boston Scientific

$37.76

-0.07 (-0.19%)

12:20
09/23/18
09/23
12:20
09/23/18
12:20
Hot Stocks
Boston Scientific announced positive 12-month data from IMPERIAL trial »

Boston Scientific…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Oct

NITE

Nightstar Therapeutics

$25.64

-1.71 (-6.25%)

12:16
09/23/18
09/23
12:16
09/23/18
12:16
Hot Stocks
Nightstar reports proof of concept data from dose escalation in XIRIUS trial »

Nightstar Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

AERI

Aerie Pharmaceuticals

$58.50

0.1 (0.17%)

, AGN

Allergan

$191.34

-1.11 (-0.58%)

04:55
09/23/18
09/23
04:55
09/23/18
04:55
Conference/Events
European Society of Retina Specialists to hold a conference »

18th Congress of EURETINA…

AERI

Aerie Pharmaceuticals

$58.50

0.1 (0.17%)

AGN

Allergan

$191.34

-1.11 (-0.58%)

ALIM

Alimera Sciences

$1.07

(0.00%)

BABY

Natus Medical

$34.45

-0.2 (-0.58%)

BHC

Bausch Health

$24.92

-0.07 (-0.28%)

BAYRY

Bayer

$0.00

(0.00%)

ELXMF

Ellex Medical Lasers

$0.00

(0.00%)

GKOS

Glaukos

$58.78

-1.69 (-2.79%)

IRIX

IRIDEX

$6.52

0.08 (1.24%)

JNJ

Johnson & Johnson

$142.85

0.85 (0.60%)

NITE

Nightstar Therapeutics

$25.64

-1.71 (-6.25%)

NVS

Novartis

$85.46

-0.505 (-0.59%)

OCUL

Ocular Therapeutix

$6.45

0.03 (0.47%)

RHHBY

Roche

$0.00

(0.00%)

SHPG

Shire

$178.32

-1.68 (-0.93%)

STAA

STAAR Surgical

$47.00

-0.9 (-1.88%)

TMDI

Titan Medical

$2.24

0.02 (0.90%)

TTNP

Titan Pharmaceuticals

$0.22

-0.2833 (-56.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 24

    Sep

  • 25

    Sep

  • 27

    Sep

  • 01

    Oct

  • 03

    Oct

  • 09

    Oct

  • 16

    Oct

  • 22

    Oct

  • 28

    Oct

  • 29

    Oct

  • 15

    Nov

  • 27

    Nov

  • 21

    Dec

  • 28

    Dec

  • 15

    Feb

  • 25

    Feb

CMCSA

Comcast

$37.91

0.1 (0.26%)

, CMCSK

Comcast

$0.00

(0.00%)

14:32
09/22/18
09/22
14:32
09/22/18
14:32
Periodicals
Comcast outbids Fox in battle for Sky, Reuters reports »

Comcast (CMCSA; CMCSK)…

CMCSA

Comcast

$37.91

0.1 (0.26%)

CMCSK

Comcast

$0.00

(0.00%)

FOX

21st Century Fox

$43.97

-0.23 (-0.52%)

FOXA

21st Century Fox

$44.33

-0.26 (-0.58%)

SKYAY

Sky

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BOKF

BOK Financial

$104.69

-0.08 (-0.08%)

, COBZ

CoBiz Financial

$23.44

0.01 (0.04%)

13:36
09/22/18
09/22
13:36
09/22/18
13:36
Conference/Events
CoBiz Financial to host special shareholder meeting »

Special Shareholder…

BOKF

BOK Financial

$104.69

-0.08 (-0.08%)

COBZ

CoBiz Financial

$23.44

0.01 (0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 27

    Sep

AMRH

AMERI Holdings

$1.44

-0.04 (-2.70%)

13:30
09/22/18
09/22
13:30
09/22/18
13:30
Conference/Events
AMERI Holdings to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

BRK.A

Berkshire Hathaway

$331,710.00

-1090 (-0.33%)

13:26
09/22/18
09/22
13:26
09/22/18
13:26
Periodicals
Berkshire Hathaway still looks underpriced, Barron's says »

Class A shares of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.